Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Staber

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Molecular Therapy. Methods & Clinical Development|May 28, 2015
piggyBac-mediated phenotypic correction of factor VIII deficiencyJanice M Staber, Molly J Pollpeter, Angela Arensdorf, et al.
Pediatric Nephrology (Berlin, Germany)|August 18, 2023
Self-concept and academic achievement in children with chronic kidney diseaseSilvia L Verhofste, Amy L Conrad, Rebecca J Johnson, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Regional brain volumes and their relationship to neurocognitive outcomes in children with severe hemophilia ASilvia Verhofste, Ahmad Al-Huniti, Marci Novak, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 23, 2016
Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-InflammationNirav Dhanesha, Prem Prakash, Prakash Doddapattar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 20, 2018
Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient MicePrakash Doddapattar, Nirav Dhanesha, Mehul R Chorawala, et al.
Blood Vessels, Thrombosis & Hemostasis|June 8, 2026
Cost comparison of efanesoctocog alfa vs conventional factor VIII therapies for major surgeries in patients with severe hemophilia AJanice M Staber, Alix Arnaud, Ion Agirrezabal, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 13, 2017
ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in MiceNirav Dhanesha, Prakash Doddapattar, Mehul R Chorawala, et al.
American Journal of Hematology|October 6, 2023
Trends in dedicated care for females with bleeding disorders within U.S. hemophilia treatment centersAllison P Wheeler, Ming Y Lim, Patricia S Huguelet, et al.
Molecular Therapy. Nucleic Acids|January 25, 2013
A Hyperactive Transposase Promotes Persistent Gene Transfer of a piggyBac DNA TransposonErin R Burnight, Janice M Staber, Pavel Korsakov, et al.
Advances in Therapy|March 26, 2026
A New Risk-Based Scoring Approach to Individualize Prophylaxis in Patients with Hemophilia A: Results from the PREDICT StudyDoris V Quon, Miguel Escobar, Lisa Boggio, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Molecular Therapy. Methods & Clinical Development|May 28, 2015
piggyBac-mediated phenotypic correction of factor VIII deficiencyJanice M Staber, Molly J Pollpeter, Angela Arensdorf, et al.
Pediatric Nephrology (Berlin, Germany)|August 18, 2023
Self-concept and academic achievement in children with chronic kidney diseaseSilvia L Verhofste, Amy L Conrad, Rebecca J Johnson, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Regional brain volumes and their relationship to neurocognitive outcomes in children with severe hemophilia ASilvia Verhofste, Ahmad Al-Huniti, Marci Novak, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 23, 2016
Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-InflammationNirav Dhanesha, Prem Prakash, Prakash Doddapattar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 20, 2018
Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient MicePrakash Doddapattar, Nirav Dhanesha, Mehul R Chorawala, et al.
Blood Vessels, Thrombosis & Hemostasis|June 8, 2026
Cost comparison of efanesoctocog alfa vs conventional factor VIII therapies for major surgeries in patients with severe hemophilia AJanice M Staber, Alix Arnaud, Ion Agirrezabal, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 13, 2017
ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in MiceNirav Dhanesha, Prakash Doddapattar, Mehul R Chorawala, et al.
American Journal of Hematology|October 6, 2023
Trends in dedicated care for females with bleeding disorders within U.S. hemophilia treatment centersAllison P Wheeler, Ming Y Lim, Patricia S Huguelet, et al.
Molecular Therapy. Nucleic Acids|January 25, 2013
A Hyperactive Transposase Promotes Persistent Gene Transfer of a piggyBac DNA TransposonErin R Burnight, Janice M Staber, Pavel Korsakov, et al.
Advances in Therapy|March 26, 2026
A New Risk-Based Scoring Approach to Individualize Prophylaxis in Patients with Hemophilia A: Results from the PREDICT StudyDoris V Quon, Miguel Escobar, Lisa Boggio, et al.
Pageof 3